Nathalie Riebel
Keine laufenden Positionen mehr
Profil
Nathalie Riebel, formerly a Director of Clinical Operations at ImClone LLC, Director of Global Quality & Inspection at Eli Lilly & Co., Director of Clinical Operations at ICON plc, Director of Clinical Operations at GSK Plc, and currently serving as the Senior Vice President of Clinical Operations at PDS Biotechnology Corp.
Ehemalige bekannte Positionen von Nathalie Riebel
| Unternehmen | Position | Ende |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2023 |
| ICON PUBLIC LIMITED COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2011 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
| GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| GSK PLC | Health Technology |
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
